Summary: Discrepancies between previous light microscopic studies on the localization of basic fibroblast growth factor (bFGF) in neuroglias and neurons of the normal rat brain prompted us to investigate, by electron microscopy, the subcellular localization of bFGF-like immunoreactivity in neuroglias and neurons of the trigeminal motor and mesencephalic nuclei. Immunostaining intensity differed from astrocyte to astrocyte; in astrocytes labeled heavily with bFGF antiserum, the precise subcellular location of immunoreaction deposits was difficult to determine, whereas mildly labeled astrocytes contained reaction products in subcellular regions apart from gliofilaments, mitochondria and Golgi apparatus. A comparison of immunostained sections with negative control ones at the light and electron microscopic levels revealed that astrocyte nuclei occasionally showed bFGF immunoreactivity.
Summary: Discrepancies between previous light microscopic studies on the localization of basic fibroblast growth factor (bFGF) in neuroglias and neurons of the normal rat brain prompted us to investigate, by electron microscopy, the subcellular localization of bFGF-like immunoreactivity in neuroglias and neurons of the trigeminal motor and mesencephalic nuclei. Immunostaining intensity differed from astrocyte to astrocyte; in astrocytes labeled heavily with bFGF antiserum, the precise subcellular location of immunoreaction deposits was difficult to determine, whereas mildly labeled astrocytes contained reaction products in subcellular regions apart from gliofilaments, mitochondria and Golgi apparatus. A comparison of immunostained sections with negative control ones at the light and electron microscopic levels revealed that astrocyte nuclei occasionally showed bFGF immunoreactivity.
Immunoreactive astrocyte processes were also found in close apposition to blood vessels. bFGF was detected mainly in intracellular structures close to free ribosomes and the endoplasmic reticulum of immunoreactive oligodendrocytes and neurons; microglias rarely showed immunostaining. The nuclei of the cells with bFGF contained immunoreaction deposits of varying intensity, mainly in the euchromatin and rarely in the heterochromatin. Occasionally, bFGF of neuroglial origin accumlated in the vicinity of the interface between neurons and neuroglias. The extracellular matrix was not immunoreactive in any of the areas examined. These findings suggest that certain populations of astrocytes and oligodendrocytes as well as neurons in the normal brain contain bFGF-like substances.
Basic fibroblast growth factor (bFGF), isolated from the brain and pituitary, has been shown to induce cell division in a variety of cell types of mesodermal origin (Gospodarowicz et al. 1983 , Esch et al. 1985 , Gospodarowicz et al. 1986a , Gospodarowicz et al. 1986b ). It facilitates the survival and neurite extension of neurons cultured from the embryonic rat cortex, fetal rat hippocampus, newborn rat cortex, ciliary ganglion, fetal mesencephalon, adult rat retina and chick spinal cord (Walicke et al. 1986 , Morrison et al. 1986 , Gensburger et al. 1987 , Schubert et al. 1987 , Unsicker et al. 1987 , Walicke 1988 , Bahr et al. 1989 , Ferrari et al. 1989 . In support of a trophic or protective effect of bFGF on neurons, previous immunohistochemical studies have demonstrated bFGF-like molecules exclusively in neurons (Pettman et al. 1986 , Janet et al. 1987 , Janet et al. 1988 , Grothe et al. 1991 ). More recently, GOrnezPinilla et al (1992) have reported the presence of bFGF not only in neurons of discrete brain nuclei but also in neuroglial cells under normal and pathologic conditions. This is in contrast to the previous notion that tissue astrocytes begin to express bFGF only in response to brain injury and ischemic insult (Finkelestein et al. 1988 , Kiyota et al. 1991 . One explanation for the discrepancy between the above immunohistochemical studies is that they employed different antibodies against bFGF. However, reexamination of bFGF immunoreactivity in the normal brain with a bFGF antiserum that has been proved to recognize exclusively neuronal bFGF, if it showed the presence of bFGF in neuroglial cells, would reconcile the results of GOmez-Pinilla et al. (1992) with those of previous studies that suggest bFGF is located in neurons but not in neuroglias (Pettman et al. 1986 , Janet et al. 1987 , Janet et al. 1988 , Grothe et al. 1991 , Matsuda et al. 1992a ). The present study correlated light and electron microscopic findings in order to re-examine the localization of bFGF immunoreaction in neuroglias and neurons of the rat mesencephalic and motor trigeminal nuclei, * To whom all correspondence should be addressed .
where our previous brief survey detectcted only neuronal bFGF (Matsuda et al. 1992a ).
Materials and Methods
Male wistar rats weighing 150 to 200 g were used in this study. All animals were housed at a constant temperature (22°C) with a 12:12 hr light-dark cycle and given food and water ad libitum. The following experiments were conducted in accordance with the Guidelines for Animal Experimentation of Ehime University School of Medicine.
Immunoblot analysis
In a study of the reactivities of bFGF antiserum to acidic FGF (aFGF), bFGF and crude extract of the rat brainstem, both factors (10 ng each, purchased from R&D Systems, Mineapolis, USA) and 20 [ig of brainstem homogenate were subjected to SDSpolyacrylamide gel electrophoresis and subsequent protein staining or immunoblot analysis as described elsewhere (Towbin et Immunoelectron microscopy in the mesencephalic and motor nuclei of the trigeminal nerve Four animals were anesthetized with pentobarbital (40 mg/kg) and perfused transcardially, first with 50 ml of saline, then with 300 ml of 4% paraformaldehyde-0.075% glutaraldehyde-0.2% picric acid in 0.1 M phosphate buffer (PB) (pH 7.4) (Somogyi and Takagi 1982). The brains were removed and cut into 40 tim sections with a microslicer. The sections were immunostained with bFGF antiserum as described elsewhere (Matsuda et al. 1992a 5) incubated overnight with peroxidase-conjugated streptavidin (DAKO) diluted 1:500 with PBS containing 0.1% Triton-X 100 and 5% BSA; (6) washed twice in PBS and once in 0.1 M Tris-HC1 buffer (pH 7.6); and (7) subjected to a modified version (Sakanaka et al. 1987 ) of the cobalt-glucose oxidase-diaminobenzidine (Co-GOD) intensification method (Itoh et al. 1979 , Oldfield et al. 1983 ). Subsequently, the sections were postfixed with 1% osmium tetroxide in 0.1 M PB (pH 7.4), dehydrated in a graded series of ethanols while being stained with 1% uranyl acetate in 70% ethanol, transferred to propylene oxide and embedded in epoxy resin. Ultrathin sections were cut with a Reichert ultramicrotome and examined in an electron microscope. Control sections were incubated with bFGF antiserum that had been adsorbed with an excess of bovine bFGF, then processed as described above. Fig. 1. aFGF (lanes 1, 3) and bFGF (lanes 2, 4) were subjected to SDS-polyacrylamide gel electrophoresis, and subsequent silver staining (lanes 1, 2) or immunoblot analysis (lanes 3, 4) with bFGF antiserum. Note that this antiserum recognizes bFGF but not aFGF (lanes 3, 4) . A crude homogenate of the brainstem, when examined with immunoblotting, exhibits a main band with the same molecular weight (18 KDa) as bFGF (lane 5). Results
The bFGF antiserum used in this study recognized purified bFGF with a molecular weight of 18 kDa, but not aFGF (Fig. 1) . Crude homogenate of the brainstem, when examined with immunoblotting, exhibited a main band with the same molecular weight as bFGF (Fig. 1) .
Immunohistochemistry
In epon-embedded sections from the mesence-phalic and motor trigeminal nuclei, many large neurons as well as putative nerve fibers were labeled with bFGF antiserum. Among the neuronal elements with bFGF immunoreactivity (bFGF-IR), immunoreactive structures smaller in diameter than nerve cell bodies and larger in size than ordinary nerve processes were scattered within the nuclei (Fig. 2a) . The immunoreactive structures, when observed in the electron microscope, showed an electron dense cytoplasm with several bundles of gliofilaments as a structural marker for astrocytes (Fig. 2b,c) . The putative astrocytes proved to exhibit weak immunostaining in the nucleus as well by comparing them with non-immunoreactive astrocytes (Fig. 2b) .
bFGF immunoreactivity was not observed in the extracellular matrix (Fig. 2c) , in contrast to the study of GOmez-Pinilla et al. (1992) . Pretreatment of bFGF antiserum with bovine bFGF abolished all immunoreactions at the light and electron microscopic levels (Fig. 2d,e) .
Immunostaining intensity varied from astrocyte to astrocyte; it was difficult to identify the subcellular locations of immunoreaction deposits in heavily stained cell bodies, whereas reaction products in the cytoplasm of other astrocytes, even though exhibiting a diffuse distribution, were not present in gliofilaments, Golgi apparatus or mitochondria (Fig. 3a,b ,c) . Occasionally, astrocyte processes with bFGF-IR were seen in close apposition to the abluminal surface of blood vessels (Fig. 3d) . Myelin sheath-forming oligodendrocytes with characteristic fine dense particles in the dark cytoplasm also contained immunoreaction deposits which were located close to free ribosomes and those associated with the endoplasmic reticulum (Fig. 4a ,b) . Immunoreaction products within the nuclei of oligodendrocytes were less numerous than in heavily stained astrocytes. Putative microglias that had an elongated nucleus containing clumped chromatin and inclusion bodies consisting of an amorphous substance were rarely labeled with bFGF antiserum (Fig. 4c,d) .
Immunopositive neurons in the trigeminal mesencephalic and motor nuclei contained bFGF-IR in subcellular sites similar to those of immunoreactive oligodendrocytes (Fig. 5a ,b) . In the nuclei of these neurons, immunoreaction deposits were distributed mainly in the euchromatin and rarely in the nucleolus or heterochromatin (Fig. 5a,c) . Occasionally, electron dense immunoreaction materials of neuroglial origin accumulated close to sites of contact between neurons and neuroglias (Fig. 5c,d ).
Discussion
In this study, bFGF immunoreaction was localized exclusively in intracellular structures. This is in contrast to the light-microscopic study of GOmez-Pinella et al. (1992) , who suggested an increase in bFGF in the extracellular matrix of the dentate gyrus after entorhinal cortex lesion or fimbria-formix transection. One explanation for this discrepancy is that under light microscopy immunopositive thin processes of astrocytes can not be distinuighsed from bFGF-like materials in the extracellular space. Moreover, our recent electron microsecopic study demonstrated that augmentation of bFGF staining after cerebral ischemia is noted in the soma and processes of astrocytes and neurons but not in extracellular matrix (Matsuda et al., unpublished data).
Since our bFGF antiserum was formed in rabbits immunized with 12 amino acids on the aminoterminal side of bFGF, it can recognize the initial site of bFGF synthesis. This study demonstrated bFGF-like materials close to free ribosomes and the rough endoplasmic reticulum of immunoreactive neurons and neuroglias, suggesting that both neurons and neuroglias synthesize bFGF. The presence of bFGF-immunoreaction in immunoreactive cell nuclei may further indicate that endogenous bFGF is transported into the nucleus and involved in RNA transcription, as suggested in previous in vitro studies (Fawcett 1986 , Bouche et al. 1987 , Murphy et al. 1988 Tessler and Neufeld 1990, Dell' Era et al. 1991) . If this is true, central bFGF may affect the gene expression of neurons and neuroglias from which it is derived. Indeed, previous studies indicate that intrinsic bFGF can mediate proliferation of cultured endothelial cells and C6 glioma cells (Schweigerer et al. 1987 , Okumura et al. 1989 .
It is not possible to state with certainty why a few astrocytes contain much larger amounts of nuclear bFGF than others. One explanation for this is that the activity of astrocytes, but not that of oligodendrocytes or microglias, can be easily modulated under normal conditions, depending on the state of neural transmission within individual brain regions. To be more specific, astrocytes, which are more actively involved in the maintenance, protection and metabolic regulation of synapses than other types of neuroglias, might require various amounts of bFGF in response to differential synaptic activities (Fawcett 1986 ).
In addition to being transported into the nuclei of nerve cells and neuroglias, bFGF might be conveyed from neuroglia to neuron. This is based on the finding that bFGF of neuroglial origin occasionally accumlates in proximity to interfaces between neurons and neuroglias. Neuron-derived bFGF may be transported into the axon terminal as well, because bFGF is frequently observed around synaptic vesicles of nerve endings that are presynaptic to nerve cell bodies and dendrites (Ferguson et al. 1990; Matsuda et al. 1992a ). However, the fact that bFGF is devoid of signal peptides and absent from the Golgi complex, where secretory proteins are incorporated into synaptic vesicles with the aid of signal peptides, makes it difficult to speculate on the ways in which bFGF is transported into nerve endings.
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